Expenses for existing trials and new trials , until all this runs its natural course the current revenue is not much use in valuing this company. Based on existing companies here in Aus and the US in the same sector we are about the cheapest. If you dont see the potential you can always sell and move on.
- Forums
- ASX - By Stock
- AVH
- this is rubbish
this is rubbish, page-2
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.82 |
Change
0.140(3.80%) |
Mkt cap ! $266.9M |
Open | High | Low | Value | Volume |
$3.83 | $3.87 | $3.77 | $1.433M | 374.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3987 | $3.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.86 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3987 | 3.820 |
2 | 860 | 3.800 |
1 | 4 | 3.780 |
1 | 2000 | 3.770 |
1 | 7963 | 3.760 |
Price($) | Vol. | No. |
---|---|---|
3.860 | 200 | 1 |
3.870 | 9629 | 2 |
3.880 | 17056 | 3 |
3.890 | 6504 | 2 |
3.900 | 8380 | 3 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online